Identifying factors affecting memory impairment progression
Predictive Factors of the Autonomy Level Change Related to Memory Disorders
NA · Hospices Civils de Lyon · NCT02302482
This study is trying to find out what factors affect how memory loss gets worse in people with Alzheimer's and related disorders by tracking their daily living skills and cognitive function over three years.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 10860 (estimated) |
| Ages | 65 Years and up |
| Sex | All |
| Sponsor | Hospices Civils de Lyon (other) |
| Locations | 2 sites (Caluire-et-Cuire and 1 other locations) |
| Trial ID | NCT02302482 on ClinicalTrials.gov |
What this trial studies
This study focuses on patients with Alzheimer's disease or related disorders, aiming to identify predictive factors that influence changes in functional autonomy levels. By developing a comprehensive database of patient medical records, the study will track approximately 1000 patients over a three-year period, assessing their cognitive function and autonomy through regular evaluations every 6 to 12 months. The interventions include standardized assessments like the Lawton Instrumental Activities of Daily Living score and the disability assessment of dementia score. The goal is to enhance understanding of how memory impairment progresses and to inform future treatment strategies.
Who should consider this trial
Good fit: Ideal candidates are patients experiencing memory impairment who are visiting a Memory Clinic for the first time and living at home or in supportive housing.
Not a fit: Patients residing in institutions or those with significant hearing or visual impairments that hinder examination will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for patients with memory impairment, enhancing their quality of life.
How similar studies have performed: Other studies have shown promise in identifying predictive factors for cognitive decline, suggesting that this approach may yield valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who undergo a medical visit in the Memory Clinic for the 1st time * Patients living at home or in housing * Patients with memory impairment, at all stage of the disease Exclusion Criteria: * Patients in institution * Patients under legal protection * Patients with a hearing or visual impairment, which dot not allow to carry out the examination
Where this trial is running
Caluire-et-Cuire and 1 other locations
- Hôpital Dugoujon — Caluire-et-Cuire, France (NOT_YET_RECRUITING)
- Hospices Civils de Lyon - Hôpital des Charpennes — Lyon, France (RECRUITING)
Study contacts
- Study coordinator: Pierre Krolak-Salmon, Professor
- Email: pierre.krolak-salmon@chu-lyon.fr
- Phone: (0)4 72 43 20 50
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Memory Impairment, Alzheimer's disease or related disorders, Functional autonomy level, Cognitive function, Predictive factors